Recently, chronic treatment of rat models of pressure overload with GSK503A, proposed to inhibit both TRPC3 and TRPC6, showed no interstitial cardiac fibrosis (Seo et al., 2014), suggesting that TRPC3 and TRPC6 are needed for the fibrosis appearance. This evidence concerns the gene TRPC6 and Interstitial cardiac fibrosis.